Filters

Phase
    Intervention Type
      Status
        Location:
        LocationClose
        Distance
          Term Search
          You can select from the dropdown list OR enter your own terms to refine the search.

          Last Updated: 10/31/2025

          Need to find the closest trial?
          Sort By Distance
          Save trials for later
          Sign Up
          Not sure about your diagnosis?
          Check Your Symptoms
          1 clinical trial found

            A Single Center Study to Evaluate the Effectiveness and Safety of ILUMYA in Combination With HALOG Ointment 0.1% for the Treatment of Moderate to Severe Plaque Psoriasis.

            A Single Center Study to Evaluate the Effectiveness and Safety of ILUMYA in Combination With HALOG Ointment 0.1% for the Treatment of Moderate to Severe Plaque Psoriasis.

            Who is this study for: Patients with moderate-to-severe plaque psoriasis
            Enrollment Status: Recruiting
            Publish Date: April 15, 2020
            Intervention Type: Drug
            Study Drug: Ilumya Injectable Product
            Study Phase: Phase 4

            Summary: Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.

            Showing 1-1 of 1

            Last Updated: 10/31/2025